(CCEP) Coca-Cola European Partners - Overview
Exchange: NASDAQ •
Country: United Kingdom •
Currency: USD •
Type: Common Stock •
ISIN: GB00BDCPN049
Stock: Beverages, Soft Drinks, Juices, Coffee, Tea
Total Rating 51
Risk 70
Buy Signal -1.28
| Risk 5d forecast | |
|---|---|
| Volatility | 26.8% |
| Relative Tail Risk | -4.94% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.35 |
| Alpha | 2.00 |
| Character TTM | |
|---|---|
| Beta | 0.307 |
| Beta Downside | 0.416 |
| Drawdowns 3y | |
|---|---|
| Max DD | 17.03% |
| CAGR/Max DD | 1.23 |
EPS (Earnings per Share)
Revenue
Description: CCEP Coca-Cola European Partners March 04, 2026
Coca-Cola Europacific Partners PLC (CCEP) produces, distributes, and sells a variety of non-alcoholic ready-to-drink beverages. This includes soft drinks, waters, juices, teas, coffees, and energy drinks.
The company operates in the beverage sector, a mature industry characterized by high brand loyalty and extensive distribution networks. CCEPs business model involves bottling and distributing products under numerous well-known brands, including Coca-Cola, Monster Energy, and Fanta, across a wide geographic footprint.
For a deeper dive into CCEPs market performance and financial health, consider exploring its profile on ValueRay.
Headlines to watch out for
- European and Asia-Pacific beverage consumption drives revenue
- Raw material and energy costs impact profitability
- Regulatory changes on sugar content affect sales
- Competition from private labels pressures market share
- Currency fluctuations influence international earnings
Piotroski VR‑10 (Strict, 0-10) 9.0
| Net Income: 3.35b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.15 > 0.02 and ΔFCF/TA 8.42 > 1.0 |
| NWC/Revenue: -3.65% < 20% (prev -2.11%; Δ -1.53% < -1%) |
| CFO/TA 0.20 > 3% & CFO 5.98b > Net Income 3.35b |
| Net Debt (10.30b) to EBITDA (6.87b): 1.50 < 3 |
| Current Ratio: 0.80 > 1.5 & < 3 |
| Outstanding Shares: last quarter (449.1m) vs 12m ago -2.37% < -2% |
| Gross Margin: 35.45% > 18% (prev 0.36%; Δ 3.51k% > 0.5%) |
| Asset Turnover: 139.6% > 50% (prev 108.8%; Δ 30.79% > 0%) |
| Interest Coverage Ratio: 9.78 > 6 (EBITDA TTM 6.87b / Interest Expense TTM 512.7m) |
Altman Z'' 2.25
| A: -0.05 (Total Current Assets 6.08b - Total Current Liabilities 7.58b) / Total Assets 29.86b |
| B: 0.30 (Retained Earnings 9.10b / Total Assets 29.86b) |
| C: 0.17 (EBIT TTM 5.01b / Avg Total Assets 29.56b) |
| D: 0.42 (Book Value of Equity 9.11b / Total Liabilities 21.56b) |
| Altman-Z'' Score: 2.25 = BBB |
Beneish M -3.04
| DSRI: 0.81 (Receivables 2.80b/2.67b, Revenue 41.26b/31.83b) |
| GMI: 1.03 (GM 35.45% / 36.49%) |
| AQI: 1.00 (AQ_t 0.59 / AQ_t-1 0.59) |
| SGI: 1.30 (Revenue 41.26b / 31.83b) |
| TATA: -0.09 (NI 3.35b - CFO 5.98b) / TA 29.86b) |
| Beneish M-Score: -3.04 (Cap -4..+1) = AA |
What is the price of CCEP shares?
As of March 21, 2026, the stock is trading at USD 91.62 with a total of 4,250,211 shares traded.
Over the past week, the price has changed by -8.80%, over one month by -13.32%, over three months by +0.27% and over the past year by +9.91%.
Over the past week, the price has changed by -8.80%, over one month by -13.32%, over three months by +0.27% and over the past year by +9.91%.
Is CCEP a buy, sell or hold?
Coca-Cola European Partners has received a consensus analysts rating of 4.00.
Therefore, it is recommended to buy CCEP.
- StrongBuy: 7
- Buy: 2
- Hold: 4
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the CCEP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 101.8 | 11.1% |
| Analysts Target Price | 101.8 | 11.1% |
CCEP Fundamental Data Overview March 17, 2026
P/E Trailing = 20.4603
P/E Forward = 19.3798
P/S = 2.1518
P/B = 4.9638
P/EG = 2.8476
Revenue TTM = 41.26b USD
EBIT TTM = 5.01b USD
EBITDA TTM = 6.87b USD
Long Term Debt = 9.22b USD (from longTermDebt, two quarters ago)
Short Term Debt = 469.8m USD (from shortTermDebt, last quarter)
Debt = 11.22b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.30b USD (from netDebt column, last quarter)
Enterprise Value = 55.24b USD (44.97b + Debt 11.22b - CCE 956.6m)
Interest Coverage Ratio = 9.78 (Ebit TTM 5.01b / Interest Expense TTM 512.7m)
EV/FCF = 12.49x (Enterprise Value 55.24b / FCF TTM 4.42b)
FCF Yield = 8.00% (FCF TTM 4.42b / Enterprise Value 55.24b)
FCF Margin = 10.72% (FCF TTM 4.42b / Revenue TTM 41.26b)
Net Margin = 8.12% (Net Income TTM 3.35b / Revenue TTM 41.26b)
Gross Margin = 35.45% ((Revenue TTM 41.26b - Cost of Revenue TTM 26.63b) / Revenue TTM)
Gross Margin QoQ = 35.19% (prev 35.34%)
Tobins Q-Ratio = 1.85 (Enterprise Value 55.24b / Total Assets 29.86b)
Interest Expense / Debt = 1.54% (Interest Expense 172.7m / Debt 11.22b)
Taxrate = 20.40% (265.0m / 1.30b)
NOPAT = 3.99b (EBIT 5.01b * (1 - 20.40%))
Current Ratio = 0.80 (Total Current Assets 6.08b / Total Current Liabilities 7.58b)
Debt / Equity = 1.43 (Debt 11.22b / totalStockholderEquity, last quarter 7.83b)
Debt / EBITDA = 1.50 (Net Debt 10.30b / EBITDA 6.87b)
Debt / FCF = 2.33 (Net Debt 10.30b / FCF TTM 4.42b)
Total Stockholder Equity = 8.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.34% (Net Income 3.35b / Total Assets 29.86b)
RoE = 40.79% (Net Income TTM 3.35b / Total Stockholder Equity 8.22b)
RoCE = 28.75% (EBIT 5.01b / Capital Employed (Equity 8.22b + L.T.Debt 9.22b))
RoIC = 20.50% (NOPAT 3.99b / Invested Capital 19.47b)
WACC = 5.89% (E(44.97b)/V(56.20b) * Re(7.05%) + D(11.22b)/V(56.20b) * Rd(1.54%) * (1-Tc(0.20)))
Discount Rate = 7.05% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.19%
[DCF] Terminal Value 88.43% ; FCFF base≈3.40b ; Y1≈4.19b ; Y5≈7.14b
[DCF] Fair Price = 442.4 (EV 208.00b - Net Debt 10.30b = Equity 197.69b / Shares 446.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -6.99 | EPS CAGR: -46.32% | SUE: 0.0 | # QB: 0
Revenue Correlation: 66.07 | Revenue CAGR: 17.42% | SUE: -0.35 | # QB: 0
EPS current Year (2026-12-31): EPS=4.45 | Chg7d=-0.014 | Chg30d=+0.002 | Revisions Net=-1 | Growth EPS=+3.9% | Growth Revenue=+2.8%
EPS next Year (2027-12-31): EPS=4.89 | Chg7d=-0.019 | Chg30d=-0.018 | Revisions Net=-1 | Growth EPS=+9.8% | Growth Revenue=+3.8%
[Analyst] Revisions Ratio: -0.11 (4 Up / 5 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 3.1% (Discount Rate 7.9% - Earnings Yield 4.9%)
[Growth] Growth Spread = +0.7% (Analyst 3.8% - Implied 3.1%)
P/E Forward = 19.3798
P/S = 2.1518
P/B = 4.9638
P/EG = 2.8476
Revenue TTM = 41.26b USD
EBIT TTM = 5.01b USD
EBITDA TTM = 6.87b USD
Long Term Debt = 9.22b USD (from longTermDebt, two quarters ago)
Short Term Debt = 469.8m USD (from shortTermDebt, last quarter)
Debt = 11.22b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 10.30b USD (from netDebt column, last quarter)
Enterprise Value = 55.24b USD (44.97b + Debt 11.22b - CCE 956.6m)
Interest Coverage Ratio = 9.78 (Ebit TTM 5.01b / Interest Expense TTM 512.7m)
EV/FCF = 12.49x (Enterprise Value 55.24b / FCF TTM 4.42b)
FCF Yield = 8.00% (FCF TTM 4.42b / Enterprise Value 55.24b)
FCF Margin = 10.72% (FCF TTM 4.42b / Revenue TTM 41.26b)
Net Margin = 8.12% (Net Income TTM 3.35b / Revenue TTM 41.26b)
Gross Margin = 35.45% ((Revenue TTM 41.26b - Cost of Revenue TTM 26.63b) / Revenue TTM)
Gross Margin QoQ = 35.19% (prev 35.34%)
Tobins Q-Ratio = 1.85 (Enterprise Value 55.24b / Total Assets 29.86b)
Interest Expense / Debt = 1.54% (Interest Expense 172.7m / Debt 11.22b)
Taxrate = 20.40% (265.0m / 1.30b)
NOPAT = 3.99b (EBIT 5.01b * (1 - 20.40%))
Current Ratio = 0.80 (Total Current Assets 6.08b / Total Current Liabilities 7.58b)
Debt / Equity = 1.43 (Debt 11.22b / totalStockholderEquity, last quarter 7.83b)
Debt / EBITDA = 1.50 (Net Debt 10.30b / EBITDA 6.87b)
Debt / FCF = 2.33 (Net Debt 10.30b / FCF TTM 4.42b)
Total Stockholder Equity = 8.22b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.34% (Net Income 3.35b / Total Assets 29.86b)
RoE = 40.79% (Net Income TTM 3.35b / Total Stockholder Equity 8.22b)
RoCE = 28.75% (EBIT 5.01b / Capital Employed (Equity 8.22b + L.T.Debt 9.22b))
RoIC = 20.50% (NOPAT 3.99b / Invested Capital 19.47b)
WACC = 5.89% (E(44.97b)/V(56.20b) * Re(7.05%) + D(11.22b)/V(56.20b) * Rd(1.54%) * (1-Tc(0.20)))
Discount Rate = 7.05% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -1.19%
[DCF] Terminal Value 88.43% ; FCFF base≈3.40b ; Y1≈4.19b ; Y5≈7.14b
[DCF] Fair Price = 442.4 (EV 208.00b - Net Debt 10.30b = Equity 197.69b / Shares 446.8m; r=5.90% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -6.99 | EPS CAGR: -46.32% | SUE: 0.0 | # QB: 0
Revenue Correlation: 66.07 | Revenue CAGR: 17.42% | SUE: -0.35 | # QB: 0
EPS current Year (2026-12-31): EPS=4.45 | Chg7d=-0.014 | Chg30d=+0.002 | Revisions Net=-1 | Growth EPS=+3.9% | Growth Revenue=+2.8%
EPS next Year (2027-12-31): EPS=4.89 | Chg7d=-0.019 | Chg30d=-0.018 | Revisions Net=-1 | Growth EPS=+9.8% | Growth Revenue=+3.8%
[Analyst] Revisions Ratio: -0.11 (4 Up / 5 Down within 30d for Current Year)
[Growth] Implied Growth Rate = 3.1% (Discount Rate 7.9% - Earnings Yield 4.9%)
[Growth] Growth Spread = +0.7% (Analyst 3.8% - Implied 3.1%)